Protamine sulphate coated poly (lactide-co-glycolide) nanoparticles of MUC-1 peptide improved cellular uptake and cytokine release in mouse antigen presenting cells

References

• Almeida, A.J., and Souto, E., 2007. Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Advanced drug delivery reviews, 59 (6), 478–490.
   PubMed Web of Science ®Google Scholar
• American Cancer Society 2019. Key statistics of small cell lung cancer Atlanta.
   Google Scholar
• Arbyn, M., et al., 2018. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors. Cochrane database systemic review, 5, CD009069.
   PubMed Web of Science ®Google Scholar
• Arulselvan, P., et al., 2016. Anti-inflammatory potential of ethyl acetate fraction of moringa oleifera in downregulating the NF-κB signaling pathway in lipopolysaccharide-stimulated macrophages. Molecules, 21 (11), 1452.
   Web of Science ®Google Scholar
• Azmi, F., et al., 2014. Recent progress in adjuvant discovery for peptide-based subunit vaccines. Human vaccines & immunotherapeutics, 10 (3), 778–796.
   PubMed Web of Science ®Google Scholar
• Behzadi, S., et al., 2017. Cellular uptake of nanoparticles: journey inside the cell. Chemical society reviews, 46 (14), 4218–4244.
   PubMed Web of Science ®Google Scholar
• Bragta, P., et al., 2018. Intratumoral administration of carboplatin bearing poly (ε-caprolactone) nanoparticles amalgamated with in situ gel tendered augmented drug delivery, cytotoxicity, and apoptosis in melanoma tumor. Colloids and surfaces B: biointerfaces, 166, 339–348.
   PubMed Web of Science ®Google Scholar
• Butts, C., et al., 2005. Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer. Journal of clinical oncology: official journal of the american society of clinical oncology, 23 (27), 6674–6681.
   PubMed Web of Science ®Google Scholar
• Chaturvedi, A.K., et al., 2011. Human papillomavirus and rising oropharyngeal cancer incidence in the United States. Journal of clinical oncology, 29 (32), 4294–4301.
   PubMed Web of Science ®Google Scholar
• Chen, H., et al., 2014. Recent progress in development of new sonosensitizers for sonodynamic cancer therapy. Drug discovery today, 19 (4), 502–509.
   PubMed Web of Science ®Google Scholar
• Cho, W.-S., et al., 2014. Surface functionalization affects the zeta potential, coronal stability and membranolytic activity of polymeric nanoparticles. Nanotoxicology, 8 (2), 202–211.
   PubMed Web of Science ®Google Scholar
• Croce, M.V., et al., 2001. Humoral immune response induced by the protein core of MUC1 mucin in pregnant and healthy women. Breast cancer research and treatment, 69 (1), 1–11.
   PubMed Web of Science ®Google Scholar
• D'Errico, G., et al., 2017. A current perspective on cancer immune therapy: Step-bystepapproach to constructing the magic bullet. Clinical and translational medicine, 6 (1), 3.
   Google Scholar
• Dhami, N.K., et al., 2014. Non-aggregated protamine-coated poly(lactide-co-glycolide) nanoparticles of cisplatin crossed blood-brain barrier, enhanced drug delivery and improved therapeutic index in glioblastoma cells: in vitro studies. Journal of microencapsulation, 31 (7), 685–693.
   PubMed Web of Science ®Google Scholar
• Finke, J.H., et al., 2014. Coumarin 6 as a fluorescent model drug: How to identify properties of lipid colloidal drug delivery systems via fluorescence spectroscopy? European journal of lipid science and technology, 116 (9), 1234–1246.
   Web of Science ®Google Scholar
• Foged, C., et al., 2005. Particle size and surface charge affect particle uptake by human dendritic cells in an in vitro model. International journal of pharmaceutics, 298 (2), 315–322.
   PubMed Web of Science ®Google Scholar
• Forest, V., and Pourchez, J., 2017. Preferential binding of positive nanoparticles on cell membranes is due to electrostatic interactions: A too simplistic explanation that does not take into account the nanoparticle protein corona. Materials science & engineering. C, materials for biological applications, 70 (Pt 1), 889–896.
   PubMed Web of Science ®Google Scholar
• Fröhlich, E., 2012. The role of surface charge in cellular uptake and cytotoxicity of medical nanoparticles. International journal of nanomedicine, 7, 5577–5591.
   PubMed Web of Science ®Google Scholar
• Gaus, K., Rodriguez, M., et al., 2005. Domain-specific lipid distribution in macrophage plasma membranes. Journal of lipid research, 46 (7), 1526–1538.
   PubMed Web of Science ®Google Scholar
• Gillison, M.L., Chaturvedi, A.K., and Lowy, D.R., 2008. HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women. Cancer, 113 (10 Suppl), 3036–3046.
   PubMed Web of Science ®Google Scholar
• Guo, C., et al., 2013. Therapeutic cancer vaccines: past, present, and future. Advances in cancer research, 119, 421–475.
   PubMed Web of Science ®Google Scholar
• Hojaee, S., and Nana-Sinkam, P., 2017. Recent advances in the management of non-small cell lung cancer. F1000Research, 6, 2110.
   PubMedGoogle Scholar
• Horváti, K., et al., 2018. Surface Layer Modification of Poly(d,l-lactic- co-glycolic acid) Nanoparticles with Targeting Peptide: A Convenient Synthetic Route for Pluronic F127-Tuftsin Conjugate. Bioconjugate chemistry, 29 (5), 1495–1499.
   PubMed Web of Science ®Google Scholar
• Jemal, A., et al., 2011. Global cancer statistics. CA: a cancer journal for clinicians, 61 (2), 69–90.
   PubMed Web of Science ®Google Scholar
• Jyoti, K., et al., 2020. Non-small cell lung cancer tumour antigen, MUC1 peptide-loaded non-aggregated poly (lactide-co-glycolide) nanoparticles augmented cellular uptake in mouse professional antigen-presenting cells: optimisation and characterisation. Journal of microencapsulation, 37 (1), 14–28.
   PubMed Web of Science ®Google Scholar
• Kamruzzaman Selim, K.M., et al., 2007. Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials, 28 (4), 710–716.
   PubMed Web of Science ®Google Scholar
• Kaur, A., et al., 2016. Tetanus toxoid-loaded cationic non-aggregated nanostructured lipid particles triggered strong humoral and cellular immune responses. Journal of microencapsulation, 33 (3), 263–273.
   PubMed Web of Science ®Google Scholar
• Kelly, R.J., and Giaccone, G., 2011. Lung Cancer Vaccines. Cancer J, 5, 302–308.
   Web of Science ®Google Scholar
• Lillehoj, E.P., et al., 2013. Cellular and molecular biology of airway mucins. International review of cell and molecular biology, 303, 139–202.
   PubMed Web of Science ®Google Scholar
• Lin, P.C., et al., 2014. Techniques for physicochemical characterization of nanomaterials. Biotechnology advances, 32 (4), 711–726.
   PubMed Web of Science ®Google Scholar
• Matsuo, K., et al., 2011. Intranasal immunization with poly(γ-glutamic acid) nanoparticles entrapping antigenic proteins can induce potent tumor immunity. Jorunal control release, 152 (2), 310–316.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay, A., Dyring, C., and Stott, D.I., 2014. Comparison of prophylactic and therapeutic immunisation with an ErbB-2 (HER2) fusion protein and immunoglobulin V-gene repertoire analysis in a transgenic mouse model of spontaneous breast cancer. Vaccine, 32 (8), 1012–1018.
   PubMed Web of Science ®Google Scholar
• Nagpal, M., et al., 2019. Optimization of sulfation of okra fruit gum for improved rheological and pharmacological properties. International journal of biological macromolecules, 122, 1–9.
   PubMed Web of Science ®Google Scholar
• Navada, S., et al., 2006. Temporal trends in small cell lung cancer: Analysis of the national Surveillance, Epidemiology, and End-Results (SEER) database. Journal of clinical oncology, 24 (18_suppl), 7082–7082.
   Web of Science ®Google Scholar
• Nembrini, C., et al., 2011. Nanoparticle conjugation of antigen enhances cytotoxic T-cell responses in pulmonary vaccination. Proceedings of the national academy of sciences of the united states of america, 108 (44), E989–97.,
   PubMed Web of Science ®Google Scholar
• Nicolete, R., dos Santos, D.F., and Faccioli, L.H., 2011. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. International immunopharmacology, 11 (10), 1557–1563.
   PubMed Web of Science ®Google Scholar
• Qin, H., et al., 2018. New advances in immunotherapy for non-small cell lung cancer. Am J transl result, 10, 2234–2245.
   PubMed Web of Science ®Google Scholar
• Saini, J., et al., 2014. Bleomycin sulphate loaded nanostructured lipid particles augment oral bioavailability, cytotoxicity and apoptosis in cervical cancer cells. Colloids and surfaces B: biointerfaces, 118, 101–110.
   PubMed Web of Science ®Google Scholar
• Sandoval, F., et al., 2013. Mucosal imprinting of vaccine-induced CD8+ T cells is crucial to inhibit the growth of mucosal tumors. Science translational medicine., 5, 172.
   Web of Science ®Google Scholar
• Sangha, R., and Butts, C., 2007. L-BLP25: a peptide vaccine strategy in non small cell lung cancer. Clin cancer res, 13, 4652–4654.
   PubMed Web of Science ®Google Scholar
• Sharma, S., et al., 2016. Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells. Materials science and engineering: c, 67, 378–385.
   PubMed Web of Science ®Google Scholar
• Syn, N.L., et al., 2017. De-novo and acquired resistance to immune checkpoint targeting. The lancet oncol, 18, 731–741.
   PubMed Web of Science ®Google Scholar
• Taciak, B., et al., 2018. Evaluation of phenotypic and functional stability of RAW 264.7 cell line through serial passages. PLoS one, 13 (6), e0198943.
   PubMed Web of Science ®Google Scholar
• Win, K.Y., and Feng, S.S., 2005. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials, 26 (15), 2713–2722.
   PubMed Web of Science ®Google Scholar
• Zaman, M., Chandrudu, S., and Toth, I., 2013. Strategies for intranasal delivery of vaccines. Drug delivery and translational research, 3 (1), 100–109.
   PubMed Web of Science ®Google Scholar